New Insight into How an Old IBD Drug Works
Although it is one of the oldest medications used to treat patients with inflammatory bowel disease (IBD) and an effective treatment for an associated arthritis condition called spondyloarthritis (SpA), sulfasalazine’s mechanism of action has been unclear.
Dr. Jennie G. Ono Named Chief of Pediatrics at NewYork-Presbyterian Queens
Dr. Jennie G. Ono, a leading pediatrician who focuses on inpatient care, newborn medicine and pediatric asthma, has been appointed chief of pediatrics at NewYork-Presbyterian Queens.
NYP Announces More Than $3 Million in Grants to Improve Community Health
NewYork-Presbyterian has awarded more than $3 million in new funding to community-based organizations (CBOs) to address social determinants of health in neighborhoods in New York City and Westchester that struggle with high rates of health disparities.
NYP WCMC Earns Recognition as a Mitral Valve Repair Reference Center from AHA and MF
NewYork-Presbyterian/Weill Cornell Medical Center Earns Recognition as a Mitral Valve Repair Reference Center from the American Heart Association and the Mitral Foundation
Apixaban No Better Than Aspirin for Preventing Stroke Recurrence in Patients with Atrial Cardiopathy
More than a decade ago, the anticoagulant apixaban, trade name Eliquis, was shown to be superior to aspirin for preventing recurrent stroke in patients with a heart condition called atrial fibrillation.
Dr. Bernhard Kühn Named Chief of the Division of Cardiology in Pediatrics at WCM and NYP Komansky
Dr. Bernhard Kühn, a leading physician-scientist who specializes in heart regeneration, has been named chief of the Division of Cardiology in the Department of Pediatrics at Weill Cornell Medicine and NewYork-Presbyterian Komansky Children’s Hospital, effective Feb. 1.
NYP Earns National Recognition for Efforts to Address Health Disparities and Work Toward Health Justice
NewYork-Presbyterian is among the first hospitals in the nation to be awarded a Health Care Equity Certification by The Joint Commission for its work to address and improve health care equity across the healthcare system.
Weill Cornell Medicine Receives Grant for Breast Cancer Diagnosis Research
Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to validate a new blood test for the early detection of breast cancer.
Page5 of 334